000 01633nam  2200361zi 4500
0019.919668
003CaOODSP
00520231130161926
006m     o  d f      
007cr cn|||||||||
008230201e202309  onca    ob   f000 0 eng d
020 |a9780660473802
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-334/2023E-PDF
24500|aScreening recommendations for chlamydia and gonorrhea during pregnancy in Canada, 2023.
264 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cSeptember 2023.
264 4|c©2023
300 |a1 online resource (1 page) : |billustration
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Recommandations de dépistage de chlamydia et gonorrhée pendant la grossesse au Canada, 2023.
500 |a"An update from the National Advisory Committee on Sexually Transmitted and Blood-Borne Infections (NAC-STBBI)."
500 |a"Pub.: 220746."
500 |a"CCDR, September 2023, vol. 49, no. 9."
504 |aIncludes bibliographical references.
650 0|aChlamydia infections|xDiagnosis|zCanada.
650 0|aGonorrhea|xDiagnosis|zCanada.
650 0|aPregnancy|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tRecommandations de dépistage de chlamydia et gonorrhée pendant la grossesse au Canada, 2023.|w(CaOODSP)9.919670
85640|qPDF|s118 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP40-334-2023-eng.pdf